Core Viewpoint - The company is actively engaging in the research and development of advanced biomaterials, specifically collaborating with universities on a significant technology project related to bionic artificial cornea development [1] Group 1: Project Development - The bionic artificial cornea research and development project is a major technology initiative supported by the Shenzhen government [1] - The project has a long research and development cycle and is currently progressing steadily according to the established plan, but has not yet entered the clinical stage [1] Group 2: Product Production - The company has achieved mass production of collagen extraction, although the current impact of collagen products on the group's financial statements is limited [1]

Company Overview - Yingke Medical's main business includes medical protection, rehabilitation care, and health therapy, with key products such as disposable gloves, wheelchairs, and hot/cold packs [1] - The company's products are widely used in medical institutions, elderly care, and food processing industries [1] Stock Performance - On August 5, Yingke Medical's stock price showed a downward trend, closing at 37.70 yuan, down 1.10 yuan from the previous trading day [1] - The stock reached a high of 39.35 yuan and a low of 37.20 yuan during the day, with an overall fluctuation of 5.54% [1] - The trading volume was 313,184 hands, with a total transaction amount of 1.2 billion yuan, resulting in a turnover rate of 6.74% [1] Market Activity - On the morning of August 5, Yingke Medical experienced a rapid decline, with a drop of over 2% within five minutes [1] - By 9:44 AM, the stock price was reported at 38.26 yuan, with a transaction volume of 247 million yuan during that period [1] Capital Flow - On August 5, the net inflow of main funds into Yingke Medical was 9.4672 million yuan, with a cumulative net inflow of 25.6825 million yuan over the past five trading days [2]

Group 1 - The stock price of Steady Medical reached 40.45 yuan as of August 5, 2025, with an increase of 0.35 yuan from the previous trading day [1] - The trading volume on that day was 46,800 hands, with a transaction amount of 1.89 billion yuan [1] - Steady Medical focuses on healthcare products, with its main business covering medical dressings and health consumer goods, widely used in medical institutions and home care scenarios [1] Group 2 - On August 5, the net outflow of main funds was 6.1651 million yuan, with a cumulative net outflow of 73.253 million yuan over the past five trading days [1] - The current total market value of the company is 23.555 billion yuan, and the price-to-earnings ratio is 23.69 times [1]

融券方面，当日融券卖出0.36万股，净买入0.21万股。 来源：金融界 8月4日，沪深两融数据显示，稳健医疗获融资买入额0.26亿元，居两市第1069位，当日融资偿还额0.31 亿元，净卖出536.40万元。 最近三个交易日，31日-4日，稳健医疗分别获融资买入0.30亿元、0.19亿元、0.26亿元。 ...

从资金流向来看，8月4日主力资金净流出3026.27万元，近五个交易日累计净流出9949.23万元。当前公 司总市值233.51亿元，流通市值70.38亿元。 截至2025年8月4日收盘，稳健医疗股价报40.10元，较前一交易日下跌0.01元，跌幅0.02%。当日成交量 为6.19万手，成交金额达2.46亿元。 稳健医疗是一家专注于医疗健康产品的企业，主营业务包括医用敷料、防护用品等产品的研发、生产和 销售。公司产品广泛应用于医疗机构和个人护理领域。 风险提示：股市有风险，投资需谨慎。 来源:金融界 ...

Core Viewpoint - The company is adapting its export strategy to the U.S. market by leveraging its overseas production capacity to mitigate tariff fluctuations [1] Group 1: Export Strategy - The current tariff rate for the company's glove products exported to the U.S. is based on the latest U.S. Customs policy [1] - After the launch of the Vietnam facility, the export tariff to the U.S. will be determined by local trade policies, which are expected to be more favorable compared to domestic exports [1] - The Malaysian tariff policy does not have a direct positive impact on the company's exports to the U.S. [1] Group 2: Production Capacity - The company primarily relies on its own overseas production capacity to address tariff fluctuations [1]

中红医疗（300981.SZ）8月1日在投资者互动平台表示，公司所生产的一次性健康防护手套，可用于医 疗检查、医疗护理、外科手术、食品加工、电子化工、家庭日用清洁卫生等领域。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问贵公司是否有基孔肯雅热的防护产品？ ...

7月30日，沪深两融数据显示，稳健医疗获融资买入额0.31亿元，居两市第1198位，当日融资偿还额0.32 亿元，净卖出89.40万元。 来源：金融界 融券方面，当日融券卖出0.01万股，净卖出0.00万股。 最近三个交易日，28日-30日，稳健医疗分别获融资买入0.95亿元、0.43亿元、0.31亿元。 ...

来源：金融界 7月29日，沪深两融数据显示，稳健医疗获融资买入额0.43亿元，居两市第1034位，当日融资偿还额0.46 亿元，净卖出243.39万元。 最近三个交易日，25日-29日，稳健医疗分别获融资买入0.63亿元、0.95亿元、0.43亿元。 融券方面，当日融券卖出0.10万股，净卖出0.04万股。 ...

7月28日，稳健医疗今日收盘41.24元，下跌2.92%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到31.54倍，总市值240.15亿元。 从行业市盈率排名来看，公司所处的美容护理行业市盈率平均41.75倍，行业中值44.75倍，稳健医疗排 名第12位。 稳健医疗用品股份有限公司的主营业务是棉类制品的研发、生产、销售。公司的主要产品是高端伤口敷 料产品、传统伤口护理与包扎产品、手术室耗材产品、感染防护产品、健康个护产品、纯棉柔巾、全棉 表层卫生巾、纯棉湿巾、无纺类消费品、婴童用品、婴童服饰、成人服饰、纺织类消费品。根据中国医 保商会统计的数据,公司已连续多年稳居中国医用敷料出口前三名。公司自主"winner"品牌已进入国内两 千多家医院和近四万家药店,其中大多数医院为三级医院,并在海王星辰、老百姓大药房等多家知名连锁 药店设有公司产品专柜;在中国香港地区"winner"品牌产品已覆盖全港全部公立和大部分私立医院。 最新一期业绩显示，2025年一季报，公司实现营业收入26.05亿元，同比36.47%；净利润2.49亿元，同 比36.26%，销售毛利率48.46%。 序号股票简称PE(TTM)P ...